HMGB1 and breast neoplasm: Although the presence of DCs within breast tumors has been associated with either anti-tumor or pro-tumor effects, the presence of DCs activated by the release of HMGB1 has been unequivocally correlated with the recruitment of T-lymphocytes recognizing tumor-associated antigens [21].